Search Results

There are 20560 results for: content related to: What was hot at the ICS meeting 2012

  1. Abstracts

    Neurourology and Urodynamics

    Volume 35, Issue S4, August 2016, Pages: S1–S471,

    Version of Record online : 5 JUL 2016, DOI: 10.1002/nau.23074

  2. Randomized, Single-Blind, Parallel Study of the Effectiveness and Safety of Solifenacin versus Propiverine in the Treatment of Overactive Bladder

    LUTS: Lower Urinary Tract Symptoms

    Volume 5, Issue 1, January 2013, Pages: 11–16, Takehiko FUKUDA, Tomonori YAMANISHI, Tomoyuki UCHIYAMA and Takao KAMAI

    Version of Record online : 9 MAY 2012, DOI: 10.1111/j.1757-5672.2012.00157.x

  3. Efficacy and Safety of Propiverine and Solifenacin for the Treatment of Female Patients with Overactive Bladder: A Crossover Study

    LUTS: Lower Urinary Tract Symptoms

    Volume 3, Issue 1, April 2011, Pages: 36–42, Naoki WADA, Masaki WATANABE, Masafumi KITA, Hiroaki OSANAI, Satoshi YAMAGUCHI, Atsushi NUMATA, Hidehiro KAKIZAKI and on behalf of the OAB Study Group in Northern Hokkaido

    Version of Record online : 9 SEP 2010, DOI: 10.1111/j.1757-5672.2010.00083.x

  4. You have free access to this content
    Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder

    International Journal of Urology

    Volume 17, Issue 9, September 2010, Pages: 796–800, Yoshinori Tanaka, Naoya Masumori and Taiji Tsukamoto

    Version of Record online : 23 JUL 2010, DOI: 10.1111/j.1442-2042.2010.02602.x

  5. Scientific Programme 44th Annual Meeting of the International Continence Society (ICS) 20—24 October 2014, Rio de Janeiro, Brazil

    Neurourology and Urodynamics

    Volume 33, Issue 6, August 2014, Pages: 631–1071,

    Version of Record online : 7 JUL 2014, DOI: 10.1002/nau.22655

    Corrected by:

    Erratum: Erratum

    Vol. 34, Issue 8, 802, Version of Record online: 25 AUG 2015

  6. Abstracts

    Neurourology and Urodynamics

    Volume 34, Issue S3, August 2015, Pages: S1–S461,

    Version of Record online : 5 JUL 2015, DOI: 10.1002/nau.22830

  7. You have free access to this content
    The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service

    BJU International

    Volume 106, Issue 4, August 2010, Pages: 506–514, Linda Cardozo, Andrew Thorpe, Juliet Warner and Manpreet Sidhu

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1464-410X.2009.09160.x

  8. Pharmacokinetics and Safety of Solifenacin Succinate in Healthy Young Men

    The Journal of Clinical Pharmacology

    Volume 44, Issue 9, September 2004, Pages: 1023–1033, Dr. Ronald A. Smulders, Mr. Walter J. Krauwinkel, Dr. Pieter J. Swart and Mr. Moses Huang

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004267592

  9. Which anticholinergic drug for overactive bladder symptoms in adults

    Intervention Review

    The Cochrane Library

    Priya Madhuvrata, June D Cody, Gaye Ellis, G Peter Herbison and E. Jean C Hay-Smith

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD005429.pub2

  10. You have free access to this content
    Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study

    BJU International

    Volume 105, Issue 8, April 2010, Pages: 1126–1135, Anders Mattiasson, Alberto Masala, Richard Morton and John Bolodeoku

    Version of Record online : 10 OCT 2009, DOI: 10.1111/j.1464-410X.2009.08910.x

  11. Rate and associated factors of solifenacin add-on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms

    International Journal of Clinical Practice

    Volume 69, Issue 4, April 2015, Pages: 444–453, H. N. Lee, K.-S. Lee, J. C. Kim, B. H. Chung, C.-S. Kim, J. G. Lee, D. K. Kim, C. H. Park, J. K. Park and S. J. Hong

    Version of Record online : 1 NOV 2014, DOI: 10.1111/ijcp.12581

  12. Scientific Programme, 43rd Annual Meeting of the International Continence Society (ICS) 26 – 30 August 2013, Barcelona, Spain

    Neurourology and Urodynamics

    Volume 32, Issue 6, August 2013, Pages: 507–932,

    Version of Record online : 8 JUL 2013, DOI: 10.1002/nau.22472

    Corrected by:

    Erratum: Erratum re: ICS abstract book. Abstract 207

    Vol. 32, Issue 8, 1149, Version of Record online: 24 OCT 2013

  13. Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: An open-label, multicenter, prospective study

    Neurourology and Urodynamics

    Volume 31, Issue 7, September 2012, Pages: 1175–1180, Jae Hoon Chung, Joo Yong Lee, Dong Hyuk Kang, U-Syn Ha, Seung Hwan Lee, Won Sik Ham, Kang Su Cho, June Hyun Han, Jinsung Park, Tag Keun Yoo and Seung Wook Lee

    Version of Record online : 30 MAY 2012, DOI: 10.1002/nau.22234

  14. Clinical Impact of Solifenacin on Generic and Symptom-Specific Quality of Life for Females with Overactive Bladder: Using the Overactive Bladder Symptom Score and Rand Medical Outcomes Study 36-Item Health Survey

    LUTS: Lower Urinary Tract Symptoms

    Volume 5, Issue 1, January 2013, Pages: 5–10, Masashi YANO, Hiroyoshi SUZUKI, Naoto KAMIYA, Tomonori KATO, Kazushi NOMURA, Hiroaki KURAMOCHI, Sho OHTA, Kazuo MIKAMI, Hiroomi NAKATSU, Tatsuya OKANO, Tetsuro ONISHI and Tomohiko ICHIKAWA

    Version of Record online : 16 MAY 2012, DOI: 10.1111/j.1757-5672.2012.00155.x

  15. You have full text access to this OnlineOpen article
    Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)

    BJU International

    Volume 120, Issue 4, October 2017, Pages: 562–575, Sender Herschorn, Christopher R. Chapple, Paul Abrams, Salvador Arlandis, David Mitcheson, Kyu-Sung Lee, Arwin Ridder, Matthias Stoelzel, Asha Paireddy, Rob van Maanen and Dudley Robinson

    Version of Record online : 8 JUN 2017, DOI: 10.1111/bju.13882

  16. Urinary Incontinence

    Dewhurst's Textbook of Obstetrics & Gynaecology, Eighth Edition

    Dudley Robinson, Linda Cardozo, Pages: 635–692, 2012

    Published Online : 5 JAN 2012, DOI: 10.1002/9781119979449.ch51

  17. You have free access to this content
    Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

    BJU International

    Volume 93, Issue 3, February 2004, Pages: 303–310, C.R. Chapple, T. Rechberger, S. Al-Shukri, P. Meffan, K. Everaert, M. Huang, A. Ridder and the YM-905 Study Group

    Version of Record online : 4 FEB 2004, DOI: 10.1111/j.1464-410X.2004.04606.x

  18. You have free access to this content
    Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice

    British Journal of Pharmacology

    Volume 145, Issue 2, May 2005, Pages: 219–227, Tomomi Oki, Shuichi Sato, Keiji Miyata and Shizuo Yamada

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706184

  19. ICS 2017 Abstracts

    Neurourology and Urodynamics

    Volume 36, Issue S3, July 2017, Pages: S1–S575,

    Version of Record online : 26 JUL 2017, DOI: 10.1002/nau.23386

  20. You have free access to this content
    Pharmacokinetic Effect of Ketoconazole on Solifenacin in Healthy Volunteers

    Basic & Clinical Pharmacology & Toxicology

    Volume 99, Issue 1, July 2006, Pages: 33–36, Pieter J. Swart, Walter J. J. Krauwinkel, Ronald A. Smulders and Neila N. Smith

    Version of Record online : 7 JUL 2006, DOI: 10.1111/j.1742-7843.2006.pto_285.x